Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma

被引:185
作者
He, Jian-Rong [1 ,2 ,3 ]
Shen, Guo-Ping [1 ,4 ]
Ren, Ze-Fang [1 ,2 ]
Qin, Han [2 ]
Cui, Cui [1 ]
Zhang, Ying [1 ]
Zeng, Yi-Xin [1 ]
Jia, Wei-Hua [1 ,2 ]
机构
[1] Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China
[3] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangzhou, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Dept Radiat Oncol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2012年 / 34卷 / 12期
基金
中国国家自然科学基金;
关键词
neutrophils; lymphocytes; prognostic factor; nasopharyngeal carcinoma; survival; PREOPERATIVE NEUTROPHIL; CIRCULATING NUMBERS; CURATIVE RESECTION; PREDICTS SURVIVAL; CANCER; RATIO; BLOOD; INFLAMMATION; PROGRESSION; PERCENTAGE;
D O I
10.1002/hed.22008
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background The purpose of this study was to evaluate the counts and percentages of differential leukocytes as prognostic indicators in patients with nasopharyngeal carcinoma (NPC). Methods This study consisted of 1410 cases identified from an established prospective cohort of 1533 patients with NPC between October 2005 and October 2007 in the Sun YatSen University Cancer Center. Multivariate Cox proportional hazards analyses were applied. Results A high percentage of lymphocyte was significantly associated with a favorable prognosis of NPC (highest vs lowest quartile, hazard ratio [HR], 95% confidence interval [CI] for overall and progression-free survival, HR, 0.71; 95% CI, 0.481.06; HR, 0.61; 95% CI, 0.430.86, respectively), whereas a high neutrophil percentage (HR, 1.62; 95% CI, 1.062.46; HR, 1.55; 95% CI, 1.102.18, respectively), and a neutrophil/lymphocyte ratio (NLR; HR, 1.57; 95% CI, 1.042.39; HR, 1.68; 95% CI, 1.192.38, respectively), were significantly related to a poor prognosis of NPC. Conclusion Pretreatment NLR and percentages of lymphocyte and neutrophil are independent prognostic factors and may serve as clinically convenient and useful biomarkers for survival of patients with NPC. (c) 2012 Wiley Periodicals, Inc. Head Neck, 2012
引用
收藏
页码:1769 / 1776
页数:8
相关论文
共 42 条
[1]   Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma [J].
An, Xin ;
Ding, Pei-Rong ;
Wang, Feng-Hua ;
Jiang, Wen-Qi ;
Li, Yu-Hong .
TUMOR BIOLOGY, 2011, 32 (02) :317-324
[2]   Metastatic renal carcinoma comprehensive prognostic system [J].
Atzpodien, J ;
Royston, P ;
Wandert, T ;
Reitz, M .
BRITISH JOURNAL OF CANCER, 2003, 88 (03) :348-353
[3]   Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio [J].
Bhatti, Imran ;
Peacock, Oliver ;
Lloyd, Gareth ;
Larvin, Michael ;
Hall, Richard I. .
AMERICAN JOURNAL OF SURGERY, 2010, 200 (02) :197-203
[4]   Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment [J].
Cho, HanByoul ;
Hur, Hye Won ;
Kim, Sang Wun ;
Kim, Sung Hoon ;
Kim, Jae Hoon ;
Kim, Young Tae ;
Lee, Kook .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (01) :15-23
[5]   Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: Results of a matched cohort analysis [J].
Chua, DTT ;
Sham, JST ;
Au, GKH ;
Choy, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (02) :334-343
[6]  
Clark E J, 2007, HPB (Oxford), V9, P456, DOI 10.1080/13651820701774891
[7]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[8]   The intriguing role of polymorphonuclear neutrophils in antitumor reactions [J].
Di Carlo, E ;
Forni, G ;
Lollini, P ;
Colombo, MP ;
Modesti, A ;
Musiani, P .
BLOOD, 2001, 97 (02) :339-345
[9]   Impact of immune parameters on long-term survival in metastatic renal cell carcinoma [J].
Donskov, F ;
von der Maase, H .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) :1997-2005
[10]  
ELHAG A, 1987, J IMMUNOL, V139, P2406